Haven't used Innopain yet?
Ask Trustburn

Ask Trustburn about Innopain

Based on 9 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Chad Rubin
Reviews 1

The service I received from the company's website was great. The team was responsive and helpful, and I was able to easily navigate through the website to find the information I needed. I would definitely recommend Innopain to others.

Tristan Marshall
Reviews 1

The service I received from Innopain exceeded my expectations. The team was knowledgeable, helpful, and provided excellent support throughout the process. The website is user-friendly and provided all the necessary information. I highly recommend Innopain.

Steve Hochrein
Reviews 1

I am very satisfied with the services provided by Innopain. They have a professional team and their website is user-friendly. The customer support is also excellent. I highly recommend Innopain to anyone looking for reliable and efficient services.

Pascal Goyffon
Reviews 1

I am really impressed with Innopain's services. The team is knowledgeable and responsive. The website is user-friendly and provides all the necessary information. I would highly recommend Innopain for their excellent services.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="innopain-com" data-lang="en"></div>
More widgets

About Innopain

Innopain is a biopharmaceutical company, based in Clermont Ferrand (France), focused on discovering and developing new chemical entities, first-in-class analgesic drugs, to treat pain, without inducing many of the side effects associated with current therapies.Their ambition is to develop innovative compounds to reach the human proof of concept (clinical trials phase 2) of efficacy and safety for moderate to severe acute and chronic pain.The development of these compounds, TREK-1 agonists, is the result of their world-class research in pharmacology and medicinal chemistry especially on the involvement of TREK-1 and its direct activation, acting downstream from the Β΅-opioid receptor (Β΅OR), having strong analgesic effects without opioid-like adverse effects.